Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Arkwright

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 5, 2006
Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic childrenPeter D Arkwright, Alex J Farragher
The Journal of Allergy and Clinical Immunology|November 10, 2019
Vertebral, pelvic, and hip fracture risk in adults with severe atopic dermatitisPeter D Arkwright, M Zulf Mughal
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2023
Challenging Best Practice of Atopic DermatitisPeter D Arkwright, Jennifer J Koplin
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Promoting Best Practice for Patients With Atopic DermatitisPeter D Arkwright, Derek K Chu
Vaccine|July 17, 2007
The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccinePaul Balmer, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|December 22, 2022
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patientsAndrew Dakin, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|May 30, 2024
Impact of rotavirus vaccination on diarrheal disease burden of children in South AmericaTanmoy Bose, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|February 21, 2023
Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of ageTia Aoun, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|September 8, 2020
Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccineWeichang Luo, Peter D Arkwright, Ray Borrow
Resuscitation|March 2, 2010
Prevalence, outcome and pre-hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester, UKJennifer A Capps, Vibha Sharma, Peter D Arkwright
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 5, 2006
Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic childrenPeter D Arkwright, Alex J Farragher
The Journal of Allergy and Clinical Immunology|November 10, 2019
Vertebral, pelvic, and hip fracture risk in adults with severe atopic dermatitisPeter D Arkwright, M Zulf Mughal
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2023
Challenging Best Practice of Atopic DermatitisPeter D Arkwright, Jennifer J Koplin
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Promoting Best Practice for Patients With Atopic DermatitisPeter D Arkwright, Derek K Chu
Vaccine|July 17, 2007
The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccinePaul Balmer, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|December 22, 2022
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patientsAndrew Dakin, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|May 30, 2024
Impact of rotavirus vaccination on diarrheal disease burden of children in South AmericaTanmoy Bose, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|February 21, 2023
Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of ageTia Aoun, Ray Borrow, Peter D Arkwright
Expert Review of Vaccines|September 8, 2020
Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccineWeichang Luo, Peter D Arkwright, Ray Borrow
Resuscitation|March 2, 2010
Prevalence, outcome and pre-hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester, UKJennifer A Capps, Vibha Sharma, Peter D Arkwright
Pageof 17